Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared and their in vitro inhibitory potency evaluated.
Design, Synthesis, and Biological Evaluation of PKD Inhibitors
Kara M. George,Marie-Céline Frantz,Karla Bravo-Altamirano,C. LaValle,M. Tandon,Stephanie S. Leimgruber,E. Sharlow,J. Lazo,Q. J. Wang,P. Wipf
Published 2011 in Pharmaceutics
ABSTRACT
PUBLICATION RECORD
- Publication year
2011
- Venue
Pharmaceutics
- Publication date
2011-04-21
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-83 of 83 references · Page 1 of 1
CITED BY
Showing 1-61 of 61 citing papers · Page 1 of 1